<DOC>
	<DOCNO>NCT00457262</DOCNO>
	<brief_summary>paraoxonase 1 involved prevent LDL HDL oxidation , increase 's activity lead low risk coronary heart disease.In postmenopausal woman , decrease paraoxonase1 activity soy protein may increase paraoxonase1 activity</brief_summary>
	<brief_title>Effects Soy Protein Serum paraoxonase1 Activity Lipoproteins Postmenopausal Women</brief_title>
	<detailed_description>In double blind clinical randomise clinical trial parallel design study done.52 postmenopausal woman randomly assign 50 g/d soy protein placebo 10 weeks.serum lipoprotein pon1 activity measure baseline 10th week.There significant increase PON ! activity significant decrease LDL-C , LDL-C/HDL-C , TC/HDL-C TG/HDL-C soy group compare placebo group .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Cessation menes 1 year , elevation 1 year Elevation FSH level Total cholesterol Triglyceride 200 mg/dl Chronic disease ( heart disease , cancer , diabetes , hepatic , kidney thyroid disease ) Antihypertensive drug Antibiotics Lipid lower drug Sex hormone treatment Hysterectomy Diet rich soy protein</criteria>
	<gender>Female</gender>
	<minimum_age>51 Years</minimum_age>
	<maximum_age>57 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>paraoxonase1 activity</keyword>
	<keyword>LDL</keyword>
	<keyword>HDL</keyword>
	<keyword>postmenopausal woman</keyword>
	<keyword>postmenopausal woman hyperlipidemia</keyword>
</DOC>